SARS-CoV-2 Spike-derived Peptide (NGVEGFNCYFPLQSY)
Antibody screening, T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, Cellular immune response
| ￥960 | |
| RP30234 | |
|
|
|
|
|
|
|
|
|
| ￥960 | |
| RP30234 | |
|
|
|
|
|
|
|
|
|
| Description | Antibody screening, T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, Cellular immune response |
| Sequence |
{Asn}{Gly}{Val}{Glu}{Gly}{Phe}{Asn}{Cys}{Tyr}{Phe}{Pro}{Leu} {Gln}{Ser}{Tyr} |
| Sequence Shortening | NGVEGFNCYFPLQSY |
| Molecular Weight | 1737.89 |
| Purity | >95% |
| Solubility | Soluble in dimethyl sulfoxide(Analytical grade) under 1mg/ml |
| Form | Lyophilized |
| Storage | Store at -20°C. Keep tightly closed. Store in a cool dry place. |
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.
